Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Solid Tumors Refractory To Standard Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06911333
What this trial is testing

AD1208 in Subjects With Any Progressive, Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumor, AdultTumor, SolidSolid Tumor+4 more
Avelos Therapeutics Inc. 36
Early research (Phase 1)Study completedNCT00022295
What this trial is testing

Phenoxodiol in Treating Patients With Refractory Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Kazia Therapeutics Limited 36
Testing effectiveness (Phase 2)Study completedNCT00416624
What this trial is testing

Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy

Who this might be right for
AnemiaLeukemiaLymphoma+4 more
Mayo Clinic 239
Testing effectiveness (Phase 2)UnknownNCT04640246
What this trial is testing

Study of TBX-3400 in Subjects With Solid Malignant Tumors Resistant or Refractory to Standard Therapies

Who this might be right for
CancerTumor, SolidRefractory Cancer
Taiga Biotechnologies, Inc. 60
Early research (Phase 1)Ended earlyNCT03494231
What this trial is testing

HLX06, a Humanized Monoclonal Antibody Targeting Human Vascular Endothelial Growth Factor Receptor-2 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor, Adult
Henlix, Inc 5
Testing effectiveness (Phase 2)Study completedNCT01253837
What this trial is testing

L19TNFα in Patients With Advanced Solid Tumors

Who this might be right for
Solid TumorsColorectal Cancer
Philogen S.p.A. 34
Early research (Phase 1)Study completedNCT01288989
What this trial is testing

Anti-VEGFR-3 Monoclonal Antibody IMC-3C5 in Subjects With Advanced Solid Tumors

Who this might be right for
Neoplasms
Eli Lilly and Company 44
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06400160
What this trial is testing

Clinical Trial of TB511 in Advanced Solid Tumors

Who this might be right for
NSCLCProstate CancerColorectal Cancer+1 more
Twinpig Biolab, Inc. 12
Large-scale testing (Phase 3)Study completedNCT00666211
What this trial is testing

Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
Vanderbilt-Ingram Cancer Center 98
Early research (Phase 1)Study completedNCT01209143
What this trial is testing

Pharmacokinetic Drug Interaction Study of the Hedgehog Pathway Inhibitor GDC-0449 in Combination With Rosiglitazone or Combined Oral Contraceptive in Patients With Locally Advanced or Metastatic Solid Tumors That Are Refractory to Standard Therapy or for Whom No Standard Therapy Exists

Who this might be right for
Solid Cancers
Genentech, Inc. 52
Early research (Phase 1)Looking for participantsNCT06883539
What this trial is testing

A Phase I Study of LXP1788 Injection with Advanced Solid Tumors.

Who this might be right for
Solid Tumor Malignancies, CancerSolid CancersSolid Tumor Cancer+6 more
LaunXP Biomedical Co., Ltd. 24
Early research (Phase 1)Ended earlyNCT01581541
What this trial is testing

PU-H71 in Patients With Solid Tumors and Low-Grade Non-Hodgkin's Lymphoma That Have Not Responded to Standard Treatment

Who this might be right for
Solid TumorsLymphoma
National Cancer Institute (NCI) 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT05605496
What this trial is testing

NP137 Clinical and Biological Activities Assessment in Patients With Advanced/Metastatic Solid Tumors Treated by Standard Anti PD-1/PD-L1 Immunotherapies

Who this might be right for
Advanced Solid TumorsMetastatic Solid Tumors
Centre Leon Berard 57
Early research (Phase 1)Study completedNCT04026321
What this trial is testing

Single-dose Escalation Study of SQ-001 Infusion to Characterize the PK Profiles of Major Sentinel Compounds in Healthy Adult Volunteers in US

Who this might be right for
Solid Tumor Refractory to Standard Therapy
Livzon Pharmaceutical Group Inc. 40
Testing effectiveness (Phase 2)Looking for participantsNCT06940349
What this trial is testing

Interventional Study to Evaluate the Combination of Palbociclib + Sunitinib as a Treatment for Advanced Solid Tumors

Who this might be right for
Solid Tumors Refractory to Standard Therapy
Rabin Medical Center 100
Early research (Phase 1)Temporarily pausedNCT03120130
What this trial is testing

Study of Amblyomin-X in Advanced Solid Tumor

Who this might be right for
Advanced Cancer
União Química Farmacêutica Nacional S/A 24
Early research (Phase 1)UnknownNCT03503604
What this trial is testing

Anti-VEGF Monoclonal Antibody hPV19 in Patients With Solid Tumors

Who this might be right for
Solid Tumors
SuZhou Stainwei Biotech Inc. 18
Early research (Phase 1)Study completedNCT00607724
What this trial is testing

GDC-0449 in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Genentech, Inc. 68
Early research (Phase 1)Study completedNCT00031031
What this trial is testing

Kanglaite Injection Phase I Study

Who this might be right for
Solid Tumors Refractory To Standard TherapyNeoplasms
KangLaiTe USA 16
Early research (Phase 1)Study completedNCT05037149
What this trial is testing

Ph. 1, Evaluation of Safety, Tolerability, PK, Anti-tumor Activity of STP707 IV in Subjects With Solid Tumors

Who this might be right for
Solid Tumor
Sirnaomics 50
Next Page